Dr. Angelika Długosz-Pokorska | cancer research |Women Researcher Award
Dr at Medical University of Łódź, Poland
A dedicated researcher and project leader at the Medical University of Lodz, Poland, with expertise in pharmacological characterization and anticancer drug development. As Principal Investigator and Co-investigator, led projects funded by prestigious grants like OPUS and SONATA, focusing on opioid peptide analogs and alpha-methylidene-delta-lactones. Supervising international student exchanges and engaging in expert activities, workshops, and editorial work. Recognized with numerous awards for scientific excellence, including Rector’s Awards and IF=8.638 for publication series on opioid mimetics and glutathione peroxidase. Committed to advancing medical science through innovative research and academic leadership.
📜 Employment History:
Research Associate (2017-present) Medical University of Lodz, Poland; Faculty of Medicine. Co-investigator (2016-2021)
Project: Rational design and pharmacological characterization of chimeric cyclic opioid peptide analogs targeting multiple receptors
Grant: OPUS 9, project ID 2015/17/B/ST5/00153. Principal Investigator (2016-2021) Project: Analysis of the anticancer activity of new synthetic alpha-methylidene-delta-lactones in selected cell lines Grant: SONATA, project ID 2015/17/D/NZ3/02226. Supervisor, Project Manager, and Principal Investigator (2018-present) Project: Analysis of the anticancer activity and molecular mechanism of action of new hybrid molecules containing uracil skeleton with an exo-cyclic methylene group Grant: PRELUDIUM13, project ID UMO-2017/25/N/NZ3/01039
📚 Short Research Training:
University of Rouen, France (2014) Laboratoire de Neuropsychopharmacologie Expérimentale
🌍 Activities:
- Expert Activity/Reviewer (2024)
Platform: Qeios - International Student Exchanges and ERASMUS Supervision (2024)
Engaging in initiatives and participating in European Union programs, overseeing ERASMUS students. - Participation in Scientific Workshops and Research Teams (2024)
Engaging in workshops aimed at exchanging experiences, self-improvement, and organization. - Editorial Work (2023-present)
Journal: Reviewer for Breast Cancer-Tokyo, ISSN 1340-6868, eISSN 1880-4233.
🏆 Awards and Distinctions:
2022: First-level Special Award for Outstanding Didactic Work by Academic Teachers Medical University of Lodz.
2020: Team Distinction from the Faculty of Chemistry Nicolaus Copernicus University in Toruń Rector’s Award Medical University of Lodz Second-degree scientific award for a series of publications titled: ‘Investigation of the Anticancer Properties of Synthetic Analogues of Compounds Isolated from Plants’. (Impact Factor – 8.034). Polish Intelligent Development Award – Nomination.
2019: Investigation of Anticancer Activity of Synthetic Analogues of Methylenolactones”, IF=4.026PTBioch Bursary Scholarship 44th FEBS Congress “From Molecules to Living Systems”. Rector’s Award Medical University of Lodz Second Prize for Publication: ‘Synthetic Analogues of Coumarin as Novel Agents with Anticancer Activity’. (Impact Factor = 4.173). Rector’s Award Medical University of Lodz Team Second award for Publication Series:
2017: Rector’s Award Medical University of Lodz First Prize for Publication Series: “Synthesis and Investigation of Biological Activity of Opioid Mimetics and Glutathione Peroxidase”. (IF=8.638). Rector’s Award Medical University of Lodz Team First Prize for Publication Series: “Anticancer Properties of Novel Synthetic Dicoumarins”. (IF=6.221) “Investigation of Anticancer Activity of Sesquiterpene Lactones”. (IF=4.994)
2016: Rector’s Award Medical University of Lodz First Prize for Publication Series: “Anticancer Properties of Novel Synthetic Lactones in Combination with Known Anticancer Drugs”. (IF = 8.835)
Publications Top Notes 📝
- Title: Synthesis of New Chiral β-Carbonyl Selenides with Antioxidant and Anticancer Activity Evaluation-Part I
- Authors: Laskowska, A., Pacuła-Miszewska, A.J., Obieziurska-Fabisiak, M., et al.
- Journal: Materials
- Year: 2024
- Volume: 17
- Pages: 1–15
- Summary: This study focuses on the synthesis of new chiral β-carbonyl selenides and evaluates their antioxidant and anticancer activities, providing valuable insights into potential therapeutic agents.
- Title: New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF7 Cancer Cells
- Authors: Długosz-Pokorska, A., Perlikowska, R., Janecki, T., et al.
- Journal: Biologics: Targets and Therapy
- Year: 2023
- Volume: 17
- Pages: 69–83
- Summary: This article presents a novel uracil analog with potential to reverse resistance to Taxol in MCF7 cancer cells, indicating its promising role as an anticancer agent.
- Title: New Uracil Analog- U-359 can Reverse Resistance to Taxol in MCF-7 cancer cells
- Authors: Długosz-Pokorska, A., Perlikowska, R., Janecki, T., et al.
- Journal: Acta Biochimica Polonica
- Year: 2023
- Volume: 70
- Pages: 56
- Summary: This study explores another uracil analog’s potential to reverse resistance to Taxol in MCF-7 cancer cells, indicating a promising avenue for further research.
- Title: The Influence of Long Carbon Chains on the Antioxidant and Anticancer Properties of N-Substituted Benzisoselenazolones and Corresponding Diselenides
- Authors: Pacuła-Miszewska, A.J., Obieziurska-Fabisiak, M., Jastrzębska, A., et al.
- Journal: Pharmaceuticals
- Year: 2023
- Volume: 16
- Pages: 1–11
- Summary: This research investigates the impact of long carbon chains on the antioxidant and anticancer properties of N-substituted benzisoselenazolones and corresponding diselenides, providing valuable insights into structure-activity relationships.
- Title: Attachment of Chiral Functional Groups to Modify the Activity of New GPx Mimetics
- Authors: Laskowska, A., Pacuła-Miszewska, A., Długosz-Pokorska, A., et al.
- Journal: Materials
- Year: 2022
- Volume: 16
- Pages: 1–14
- Summary: This study explores the modification of GPx mimetics’ activity through the attachment of chiral functional groups, offering potential strategies for enhancing therapeutic effects.